NCT01782066View on ClinicalTrials.gov

Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Meningococcal Disease
Interventions
BIOLOGICAL

MEN-ACYW135 reduced-dose intradermal administration

Modified traditional dose escalation rule (TER) in an adaptive design. The study will be performed in duplicate, with 2 vaccines.

Trial Locations (1)

2333ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT01782066 - Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines | Biotech Hunter | Biotech Hunter